Found 120 matching trials
EA2176: Phase 3 Clinical Trial of Carboplatin and Paclitaxel +/- Nivolumab in Metastatic Anal Cancer Patients PHASE3 This phase 3 trial compares the addition of nivolumab to chemotherapy (carb...
Show More Status
Active Not Recruiting
Location
Anchorage Associates in Radiation Medicine
Learn More & Join Trial
A Study of Several Radiation Doses for Patients With Progression on Immunotherapy/Checkpoint Inhibitors PHASE2 Drugs called checkpoint inhibitors help the immune system fight cancer. Whe...
Show More Status
Active Not Recruiting
Location
Hartford Healthcare
Learn More & Join Trial
CIML NK Cell in Head & Neck Cancer PHASE1 This research study is evaluating the safety and efficacy of a combination ...
Show More Location
Dana Farber Cancer Institute
Learn More & Join Trial
Combination Therapy for PD-1 Resistant Recurrent or Metastatic Nasopharyngeal Carcinoma: A Bayesian Adaptive Phase II Trial PHASE2 This is a prospective, Bayesian adaptive, phase II clinical trial designed ...
Show More Location
Cancer Center of Guangzhou Medical University
Learn More & Join Trial
Gene-Modified Immune Cells (FH-MCVA2TCR) in Treating Patients With Metastatic or Unresectable Merkel Cell Cancer PHASE1 This phase I/II trial studies the side effects of gene-modified immune cell...
Show More Location
Fred Hutch/University of Washington Cancer Consortium
Learn More & Join Trial
Efficacy And Safety Of Anti-PD-1/PD-L1 Antibodies In Combination With Bevacizumab And Metronomic Cyclophosphamide In Patients With Non-Small Cell Lung Cancer And Cutaneous Melanoma Previously Treated With Immune Checkpoint Blockade PHASE2 This study will evaluate efficacy and safety of anti-PD-1/PD-L1 antibodies ...
Show More Location
EuroCityClinic LLC
Learn More & Join Trial
Safety and Efficacy of Yiwoxidan Anti (AK112) Monotherapy in Patients With Metastatic Renal Clear Cell Carcinoma Who Are Intolerant to TKI Treatment: a Prospective, Single Arm, Phase II Clinical Study PHASE2 This study is testing a new medicine called AK112 (Yivoximab) for people wi...
Show More Status
Enrolling By Invitation
Location
Sun Yat-sen University Cancer Center
Learn More & Join Trial
Triple Immune Checkpoint Inhibition for Advanced or Metastatic PD-(L)1 Refractory Merkel Cell Carcinoma PHASE2 This phase II trial tests how well a combination of three immunotherapy dru...
Show More Status
Active Not Recruiting
Location
Fred Hutch/University of Washington Cancer Consortium
Learn More & Join Trial
Oral Decitabine/Cedazuridine (DEC-C) in Combination With Nivolumab for Patients With Mucosal Melanoma PHASE1 Activation of the RIG-I innate immune pathway and increased expression of t...
Show More Status
Active Not Recruiting
Location
University of Colorado Hospital
Learn More & Join Trial
rHSC-DIPGVax Plus Checkpoint Blockade for the Treatment of Newly Diagnosed DIPG and DMG PHASE1 This is a phase I, open label, plus expansion clinical trial evaluating the...
Show More Location
Children's Health Orange County (CHOC)
Learn More & Join Trial